Personal Cfo Solutions, LLC Genmab A/S Transaction History

Personal Cfo Solutions, LLC

  • $704 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$33.8 - $47.06 $30,960 - $43,106
-916 Reduced 14.09%
5,584 $236,000
Q3 2022

Nov 01, 2022
BUY
$31.52 - $373.61 $204,880 - $2.43 Million
6,500 New
6,500 $209,000
Q1 2022

May 02, 2022
SELL
$30.95 - $39.68 $187,340 - $240,183
-6,053 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$35.87 - $47.12 $13,881 - $18,235
-387 Reduced 6.01%
6,053 $239,000
Q3 2021

Nov 18, 2021
BUY
$41.55 - $48.72 $267,582 - $313,756
6,440 New
6,440 $281,000

Others Institutions Holding GMAB

# of Institutions
236
Shares Held
52.5M
Call Options Held
10.2K
Put Options Held
25.5K
View Full List

About GENMAB A/S

GMAB Quotes by TradingView
  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email